Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.31 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | CASP1 | P29466 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | CASP7 | P55210 | 1/20 | 0.30 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12428243 | 0.81 | PRF1 (0.37) | ACHEMEN1ALDH1A1LMNAMAPT | |
| SCHEMBL12428209 | 0.78 | ADRB2 (0.36) | ACHEMEN1ALDH1A1LMNAMAPT | |
| SCHEMBL12428440 | 0.76 | MEN1 (0.37) | ACHEMEN1ALDH1A1LMNAMAPT | |
| SCHEMBL12428438 | 0.72 | PRF1 (0.39) | ACHEMEN1ALDH1A1LMNAMAPT | |
| SCHEMBL12428460 | 0.72 | KMT2A (0.39) | ACHEMEN1ALDH1A1LMNAMAPT | |
| SCHEMBL12428450 | 0.71 | KMT2A (0.39) | MEN1ALDH1A1LMNAMAPTKMT2A | |
| SCHEMBL12428462 | 0.71 | KMT2A (0.38) | ACHEMEN1ALDH1A1LMNAMAPT | |
| SCHEMBL12428225 | 0.71 | ADRB2 (0.35) | ACHE | |
| SCHEMBL12428242 | 0.71 | EP300 (0.37) | MEN1ALDH1A1LMNAMAPTKMT2A | |
| SCHEMBL12428485 | 0.71 | KMT2A (0.42) | ACHEMEN1ALDH1A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7977570-B2 | Dye-sensitized photoelectric conversion device | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2011-07-12 | — | — | US | disclosed |
| US-20090084441-A1 | Dye-sensitized photoelectric conversion device | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090084441-A1 | Dye-sensitized photoelectric conversion device | CRY1, H1-5, H1-0 | ACHE 2494/4885MEN1 251/4885ALDH1A1 235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.